Quality of life of patients with arterial hypertension, obesity and gout

Aim. To investigate the quality of life in patients with comorbid diseases - hypertension, obesity and gout. Material and Methods. The study involved 120 patients, including 80 patients with arterial hypertension stage II 2 degrees combined with obesity and gout assigned to the main group; compar...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	M.O. Vatseba
Formato:	article
Lenguaje:	EN UK
Publicado:	Danylo Halytsky Lviv National Medical University 2017
Materias:	quality of life, hypertension, gout, obesity Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ee5d74451fda40e9a90b3834655d6947
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ee5d74451fda40e9a90b3834655d6947
record_format	dspace
spelling	oai:doaj.org-article:ee5d74451fda40e9a90b3834655d69472021-11-10T19:50:04ZQuality of life of patients with arterial hypertension, obesity and gout1029-42442415-330310.25040/aml2017.01.004https://doaj.org/article/ee5d74451fda40e9a90b3834655d69472017-04-01T00:00:00Zhttps://amljournal.com/index.php/journal/article/view/158https://doaj.org/toc/1029-4244https://doaj.org/toc/2415-3303Aim. To investigate the quality of life in patients with comorbid diseases - hypertension, obesity and gout. Material and Methods. The study involved 120 patients, including 80 patients with arterial hypertension stage II 2 degrees combined with obesity and gout assigned to the main group; comparison group consisted of 40 patients with arterial hypertension stage II 2 degrees without obesity and gout. Patients of the main group (n = 80) were divided according to the degree of obesity: 40 patients with obesity of the first degree, 22 patients - second degree and 18 patients - third degree. In order to compare the studied parameters with normal variations, 15 healthy individuals were examined. The assessment of health was carried out using questionnaires - HAQ (Health Assessment Questionnaire); the assessment of quality of life - according to the EuroQol-5 (Europian Quality of Life Questionnaire) and the Short Form-36 (SF-36) Health Status Questionnaire. SF-36 consists of 36 items grouped into 8 scales: physical activity (Physical Functioning - PF); role of physical problems in limiting life activity (Role-Physical - RP); the intensity of pain (Bodily Pain - BP); general health (General Health - GH); vitality (Vitality - VT); social activity (Social Functioning - SF); role of emotional issues in limiting life activity (Role-Emotional - RE); Mental Health (Mental Health - MH). Physical status was evaluated on five scales - (PF, RP, BP, GH, VT), psychosocial status - on scales RE, SF, MH, GH, VT. Results and Discussion. All questionnaires that were used to assess the quality of life and health of patients, have shown that obesity and gout, as chronic progressive diseases, adversely affect the quality of life and decrease the patients' health, functional activity, and the ability of self-service. Using the questionnaires HAQ, EuroQol-5 and SF-36 revealed deterioration of the quality of life in patients with comorbid disorders; limitations of daily physical activity showed significantly higher rates in patients of the main group (p<0,001). The total physical health component (PF, RP, BP, GH, VT) and the value of psychological component of health (RE, SF, MH, GH, VT), according to the questionnaire SF-36 in the main group were significantly lower than in the comparison group (p<0,001). The most reduced were the indicators characterizing the physical health. This indicated that obesity and gout significantly limit physical activity of patients and their ability to tolerate exercise and perform daily activities; patients also showed lower resistance to disease. Average indexes of viability (p<0,001) and social functioning of the main group (p <0,001) were lower than the comparison group and showed limitations of vital activity and social contacts. The role emotional functioning did not differ significantly from the average population values. Conclusions. The data on the evaluation of the quality of life of patients with arterial hypertension, obesity and gout determine the social significance of comorbidity - obesity and gout, and the necessity of in-depth research of this comorbid condition.M.O. VatsebaDanylo Halytsky Lviv National Medical Universityarticlequality of life, hypertension, gout, obesityMedicine (General)R5-920ENUKActa Medica Leopoliensia, Vol 23, Iss 1-2, Pp 4-8 (2017)
institution	DOAJ
collection	DOAJ
language	EN UK
topic	quality of life, hypertension, gout, obesity Medicine (General) R5-920
spellingShingle	quality of life, hypertension, gout, obesity Medicine (General) R5-920 M.O. Vatseba Quality of life of patients with arterial hypertension, obesity and gout
description	Aim. To investigate the quality of life in patients with comorbid diseases - hypertension, obesity and gout. Material and Methods. The study involved 120 patients, including 80 patients with arterial hypertension stage II 2 degrees combined with obesity and gout assigned to the main group; comparison group consisted of 40 patients with arterial hypertension stage II 2 degrees without obesity and gout. Patients of the main group (n = 80) were divided according to the degree of obesity: 40 patients with obesity of the first degree, 22 patients - second degree and 18 patients - third degree. In order to compare the studied parameters with normal variations, 15 healthy individuals were examined. The assessment of health was carried out using questionnaires - HAQ (Health Assessment Questionnaire); the assessment of quality of life - according to the EuroQol-5 (Europian Quality of Life Questionnaire) and the Short Form-36 (SF-36) Health Status Questionnaire. SF-36 consists of 36 items grouped into 8 scales: physical activity (Physical Functioning - PF); role of physical problems in limiting life activity (Role-Physical - RP); the intensity of pain (Bodily Pain - BP); general health (General Health - GH); vitality (Vitality - VT); social activity (Social Functioning - SF); role of emotional issues in limiting life activity (Role-Emotional - RE); Mental Health (Mental Health - MH). Physical status was evaluated on five scales - (PF, RP, BP, GH, VT), psychosocial status - on scales RE, SF, MH, GH, VT. Results and Discussion. All questionnaires that were used to assess the quality of life and health of patients, have shown that obesity and gout, as chronic progressive diseases, adversely affect the quality of life and decrease the patients' health, functional activity, and the ability of self-service. Using the questionnaires HAQ, EuroQol-5 and SF-36 revealed deterioration of the quality of life in patients with comorbid disorders; limitations of daily physical activity showed significantly higher rates in patients of the main group (p<0,001). The total physical health component (PF, RP, BP, GH, VT) and the value of psychological component of health (RE, SF, MH, GH, VT), according to the questionnaire SF-36 in the main group were significantly lower than in the comparison group (p<0,001). The most reduced were the indicators characterizing the physical health. This indicated that obesity and gout significantly limit physical activity of patients and their ability to tolerate exercise and perform daily activities; patients also showed lower resistance to disease. Average indexes of viability (p<0,001) and social functioning of the main group (p <0,001) were lower than the comparison group and showed limitations of vital activity and social contacts. The role emotional functioning did not differ significantly from the average population values. Conclusions. The data on the evaluation of the quality of life of patients with arterial hypertension, obesity and gout determine the social significance of comorbidity - obesity and gout, and the necessity of in-depth research of this comorbid condition.
format	article
author	M.O. Vatseba
author_facet	M.O. Vatseba
author_sort	M.O. Vatseba
title	Quality of life of patients with arterial hypertension, obesity and gout
title_short	Quality of life of patients with arterial hypertension, obesity and gout
title_full	Quality of life of patients with arterial hypertension, obesity and gout
title_fullStr	Quality of life of patients with arterial hypertension, obesity and gout
title_full_unstemmed	Quality of life of patients with arterial hypertension, obesity and gout
title_sort	quality of life of patients with arterial hypertension, obesity and gout
publisher	Danylo Halytsky Lviv National Medical University
publishDate	2017
url	https://doaj.org/article/ee5d74451fda40e9a90b3834655d6947
work_keys_str_mv	AT movatseba qualityoflifeofpatientswitharterialhypertensionobesityandgout
_version_	1718439734911434752

Quality of life of patients with arterial hypertension, obesity and gout

Ejemplares similares